Arkema has plans to make fresh investments at its Changshu site in China in order to increase its Kynar fluoropolymer capacities by 35 %. The move is being undertaken in the backdrop of growing demand from the lithium-ion battery business and significant opportunities in the water filtration, construction coatings, and semiconductor industries.

Adani Green Energy (Agel) is claimed to be one of the world’s largest solar developers and the deal between Total and the Adani Group is expected to strengthen the relationship between the two companies. Adani and Total aim to be the leading participants in the sustainable economy of the future.

Air Liquide has developed a new 20 MW PEM electrolyzer which is now producing up to 8.2 tons per day of low-carbon hydrogen in Bécancour, Québec, Canada. The electrolysis unit is equipped with the Cummins technology and is expected to meet the growing demand for low-carbon hydrogen in North America.

Intravacc will spearhead a consortium to begin the concept design for a multifunctional, high-capacity vaccine plant in The Netherlands which will help the country to produce sufficient vaccines during the Covid-19 pandemic. The CDMO organization has also developed a new pilot vaccine production plant which will be operational soon.

Under a cooperation agreement signed between Total and Engie, both the companies will work together to develop and build the Masshylia project, France's largest renewable hydrogen production site, for producing green hydrogen from 100 % renewable electricity.

A new hydrogen development and testing facility is to leverage and expand Ricardo's capabilities in building solutions to support zero-emission mobility. It will also become part of a global center of excellence for hydrogen, renewable fuels and electrified transportation technology.

Honeywell UOP has been selected by Hengyi Industries to provide advanced reforming and aromatics technologies to its integrated petrochemical complex in Pulau Muara Besar, Brunei. With this move, the company aims to further expand its aromatics plant and cater to the rising demand for paraxylene in the region.

On January 28, OCI held a groundbreaking ceremony for a new plant of P&O Chemical, a joint venture with Posco Chemical at the National Industrial Complex in Gwangyang, Jeollanam-do, Korea.

The year 2020 was a promising year for bio-based polymers: Sold out PLA in 2019 has led to the installation of increased capacities, PE and PP made from bio-based naphtha are breaking ground and future expansion for bio-based polyamides as well as for PBAT, PHAs and casein polymers is on the horizon. A lower production is only observed for bio-based PET.

The new cell therapy manufacturing facility is currently under construction and is located in Devens, Massachusetts, USA. The project will enable the company to expand its global footprint and support commercial manufacturing of transformative cell therapies.